PROCEPT BioRobotics Corp - COMMON STOCK (PRCT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
PRCT on Nasdaq
Shares outstanding
55,447,593
Price per share
$29.12
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
56,088,478
Total reported value
$1,764,484,373
% of total 13F portfolios
0%
Share change
-259,391
Value change
-$27,681,523
Number of holders
255
Price from insider filings
$29.12
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PROCEPT BioRobotics Corp - COMMON STOCK (PRCT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 8.3% $146,385,004 4,653,111 FMR LLC 31 Dec 2025
ALLIANCEBERNSTEIN L.P. 6.1% $122,052,091 3,419,784 AllianceBernstein L.P. 30 Sep 2025
T. Rowe Price Investment Management, Inc. 5.9% $100,039,657 3,271,408 T. Rowe Price Investment Management, Inc. 31 Dec 2025
BNP Paribas Asset Management Holding S.A. 5.5% $94,634,366 3,094,649 BNP Paribas Asset Management Holding S.A. 31 Dec 2025

As of 31 Dec 2025, 255 institutional investors reported holding 56,088,478 shares of PROCEPT BioRobotics Corp - COMMON STOCK (PRCT). This represents 101% of the company’s total 55,447,593 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PROCEPT BioRobotics Corp - COMMON STOCK (PRCT) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.4% 5,202,306 -0.06% 0% $163,664,546
FMR LLC 8.4% 4,653,111 -42% 0.01% $146,386,864
BlackRock, Inc. 7.8% 4,347,033 +3% 0% $136,757,659
ALLIANCEBERNSTEIN L.P. 6.1% 3,385,422 -1% 0.03% $106,505,376
T. Rowe Price Investment Management, Inc. 5.9% 3,271,408 +59% 0.06% $102,919,000
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 5.6% 3,094,649 +183% 0.11% $97,357,000
MACKENZIE FINANCIAL CORP 2.8% 1,573,405 +8.2% 0.06% $49,511,860
Artisan Partners Limited Partnership 2.7% 1,520,700 +11% 0.07% $47,841,222
STATE STREET CORP 2.7% 1,489,029 +12% 0% $46,844,852
Champlain Investment Partners, LLC 2.6% 1,441,034 +0.22% 0.46% $45,334,930
Prosight Management, LP 2.5% 1,380,000 +1692% 9% $43,414,800
ArrowMark Colorado Holdings LLC 2.4% 1,349,831 +20% 0.93% $42,465,683
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,328,514 +1.6% 0% $41,802,740
Chicago Capital, LLC 2.1% 1,190,995 -24% 0.93% $37,468,687
UBS Group AG 1.9% 1,052,944 +11% 0.01% $33,125,618
BAILLIE GIFFORD & CO 1.8% 1,015,978 +18% 0.03% $31,962,667
MORGAN STANLEY 1.5% 843,491 -0.02% 0% $26,536,254
PRICE T ROWE ASSOCIATES INC /MD/ 1.3% 705,740 -19% 0% $22,204,000
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 1.3% 699,971 +2.2% 0.03% $22,021,088
Rhenman & Partners Asset Management AB 1.1% 611,000 +57% 1.8% $19,222,060
NORTHERN TRUST CORP 1% 553,103 +11% 0% $17,400,621
GOLDMAN SACHS GROUP INC 0.93% 517,732 +88% 0% $16,287,849
Bellevue Group AG 0.93% 515,430 +11% 0.31% $16,215,428
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 462,373 +0.47% 0% $14,546,255
BANK OF AMERICA CORP /DE/ 0.78% 431,205 +6.7% 0% $13,565,709

Institutional Holders of PROCEPT BioRobotics Corp - COMMON STOCK (PRCT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 56,088,478 $1,764,484,373 -$27,681,523 $31.46 255
2025 Q3 57,841,334 $2,064,355,728 +$58,548,802 $35.69 240
2025 Q2 53,324,298 $3,071,191,009 +$166,390,640 $57.60 268
2025 Q1 50,441,243 $2,938,766,560 -$31,409,190 $58.26 277
2024 Q4 50,343,754 $4,055,248,024 +$360,452,580 $80.52 279
2024 Q3 45,709,508 $3,653,668,263 +$135,461,273 $80.12 247
2024 Q2 43,960,206 $2,685,525,179 -$132,419,664 $61.09 199
2024 Q1 45,557,093 $2,251,459,753 +$4,603,354 $49.42 161
2023 Q4 45,620,767 $1,912,068,256 +$51,914,421 $41.91 144
2023 Q3 44,490,169 $1,459,568,563 +$274,904,884 $32.81 126
2023 Q2 35,958,665 $1,271,025,645 +$114,407,722 $35.35 117
2023 Q1 32,981,587 $936,651,489 -$8,052,530 $28.40 111
2022 Q4 32,804,052 $1,362,629,543 -$35,665,010 $41.54 112
2022 Q3 33,681,921 $1,396,307,426 -$142,581,938 $41.46 100
2022 Q2 34,861,572 $1,139,650,723 +$126,543,346 $32.69 92
2022 Q1 30,975,874 $1,083,745,329 +$68,880,476 $34.99 58
2021 Q4 29,451,521 $732,329,128 +$46,766,132 $25.01 60
2021 Q3 27,226,333 $1,027,223,763 +$988,368,763 $38.15 57